Work

A Phase II Trial Of Epigenetic Modulators Vorinostat In Combination With Azacitidine (azaC) In Patients With The Myelodysplastic Syndrome (MDS): Initial Results Of Study 6898 Of The New York Cancer Consortium

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.386.386

Authors: Lewis R. Silverman, Amit Verma, Rosalie Odchimar-Reissig, Eric J. Feldman, Shyamala C. Navada, Erin P Demakos, Maria R. Baer, Vesna Najfeld, Joseph A Sparano, Richard Piekarz

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Albert Einstein College of Medicine, NewYork–Presbyterian Hospital, University of Maryland, Baltimore, Montefiore Medical Center, National Institutes of Health, National Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980022549

FWCI: 3.631

Cites:

Cited by: 27

Related to: 10